Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy
- PMID: 25616656
- DOI: 10.1177/1078155214568582
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy
Abstract
BCR-ABL inhibitors administered in conjunction with chemotherapy have significantly improved outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia but, for patients diagnosed during pregnancy, data on risks to the fetus are limited. We report a woman treated with chemotherapy and imatinib mesylate who delivered a healthy baby at 30 weeks, and we discuss available data.
Keywords: Acute lymphoblastic leukemia; imatinib mesylate; pregnancy.
© The Author(s) 2015.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
